WWM
PFE icon

Willingdon Wealth Management’s Pfizer PFE Stock Holding History

Willingdon Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$5.96M Buy
192,339
+9,964
+5% +$340K 1.5% 20
2019
Q4 		$6.78M Buy
182,375
+5,412
+3% +$193K 1.39% 21
2019
Q3 		$6.03M Buy
176,963
+5,004
+3% +$182K 1.33% 20
2019
Q2 		$7.07M Buy
171,959
+5,665
+3% +$225K 1.64% 12
2019
Q1 		$6.7M Buy
166,294
+3,713
+2% +$149K 1.64% 13
2018
Q4 		$6.73M Buy
162,581
+4,316
+3% +$179K 1.94% 7
2018
Q3 		$6.62M Buy
158,265
+347
+0.2% +$13.4K 1.81% 9
2018
Q2 		$5.44M Sell
157,918
-249
-0.2% -$8.51K 1.66% 12
2018
Q1 		$5.33M Sell
158,167
-19,434
-11% -$668K 1.68% 10
2017
Q4 		$6.1M Buy
177,601
+1,031
+0.6% +$35.2K 2.01% 8
2017
Q3 		$5.98M Buy
176,570
+105,711
+149% +$3.4M 2.18% 5
2017
Q2 		$2.26M Buy
70,859
+239
+0.3% +$7.54K 0.9% 53
2017
Q1 		$2.29M Buy
70,620
+1,985
+3% +$62.6K 0.93% 41
2016
Q4 		$2.12M Buy
68,635
+2,829
+4% +$86.4K 1% 39
2016
Q3 		$2.11M Buy
65,806
+697
+1% +$23.3K 1.07% 32
2016
Q2 		$2.17M Buy
65,109
+4,069
+7% +$130K 1.12% 30
2016
Q1 		$1.72M Buy
61,040
+8,463
+16% +$242K 1.05% 39
2015
Q4 		$1.61M Buy
52,577
+2,453
+5% +$77.2K 1.47% 28
2015
Q3 		$1.49M Sell
50,124
-995
-2% -$31.9K 1.78% 18
2015
Q2 		$1.63M Sell
51,119
-40,811
-44% -$1.33M 1.56% 19
2015
Q1 		$3.03M Sell
91,930
-20,561
-18% -$654K 2.52% 6
2014
Q4 		$3.33M Sell
112,491
-1,352
-1% -$38.8K 2.09% 11
2014
Q3 		$3.19M Buy
113,843
+2,934
+3% +$82.3K 2.1% 10
2014
Q2 		$3.12M Buy
110,909
+1,720
+2% +$49K 2.16% 10
2014
Q1 		$3.33M Sell
109,189
-326
-0.3% -$9.72K 2.34% 9
2013
Q4 		$3.18M Buy
+109,515
New +$3.19M 2.5% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Willingdon Wealth Management's PFE Position: Q1 2020 in Review

Willingdon Wealth Management increased its Pfizer (PFE) stake by 5.5% in Q1 2020, buying an estimated $340K and bringing the position to 192,339 shares worth $5.96M. The position accounts for 1.5% of the portfolio, ranked #20.

Willingdon Wealth Management first reported a position in PFE in Q4 2013 and has held it in 26 quarters since. The position peaked at $7.07M in Q2 2019. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Willingdon Wealth Management held 192,339 shares of Pfizer worth $5.96M as of Q1 2020.
  • Willingdon Wealth Management bought 9,964 Pfizer shares in Q1 2020, an estimated $340K.
  • Pfizer made up 1.5% of Willingdon Wealth Management's portfolio in Q1 2020, its #20 holding.
  • Willingdon Wealth Management first reported a position in Pfizer in Q4 2013 and has held it in 26 quarters since.
  • Willingdon Wealth Management's Pfizer position peaked at $7.07M in Q2 2019.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.